Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCPMasashi Iwamoto, Takaji Wakita, Masayoshi Fukasawa et al.|Biochemical and Biophysical Research Communications|2013Cited by 330
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting PolypeptideManabu Kaneko, Takaji Wakita, Koichi Watashi et al.|Journal of Virology|2015Cited by 97